Donohoe v Britz

The High Court of Australia considered an appeal by Donohoe against a decision of the Supreme Court of New South Wales concerning the importation of proprietary medicines. The dispute arose from the valuation of these medicines for the purposes of customs duty, with the importer, Donohoe, allegedly making an untrue declaration regarding their value. The core of the matter involved the interpretation and application of provisions within the *Commonwealth Customs Act 1901* and the *Customs Tariff 1902*.

The central legal issues before the High Court were: firstly, whether the declarations made by Donohoe regarding the "ordinary market value in the country whence imported" were untrue, thereby contravening section 234(e) of the *Customs Act*; secondly, the correct method for determining the value for duty of proprietary medicines under the relevant legislation; and thirdly, the legal effect of the *Customs Tariff 1902*, particularly its retrospective application and validation of collections made under earlier tariff proposals, in light of sections 4, 5, and 6 of that Act.

The Court's reasoning focused on the interpretation of "ordinary market value" and the evidentiary burden placed upon the importer. It was held that the value for duty should be the price at which the goods would be ordinarily sold in the principal markets of the country of export. The Court found that the declarations made by Donohoe were indeed untrue, as the stated values did not reflect this ordinary market value. Furthermore, the Court affirmed the validity of the retrospective provisions of the *Customs Tariff 1902*, confirming that collections made under tariff proposals prior to the Act's formal passage were lawful.

The High Court dismissed the appeal, upholding the decision of the Supreme Court of New South Wales.